Research

Get the latest details on current events, medical progress, and therapies used by mesothelioma patients around the globe. Learn More.

Europe | International | New Studies | Research | Statistics

Risk of Mesothelioma in Women May be Underestimated
ByAlex Strauss May 29, 2021

An international team of occupational health experts says science has done a “profound disservice” by underestimating the risk of mesothelioma…

Read More Risk of Mesothelioma in Women May be Underestimated
Biomarkers | Diagnosis | Europe | Immune Systems | International | Research

Higher PD-L1 Protein May Predict Shorter Mesothelioma Survival
ByAlex Strauss May 21, 2021

Mesothelioma patients with higher levels of the PD-L1 protein in their tumor cells have worse overall survival compared to those…

Read More Higher PD-L1 Protein May Predict Shorter Mesothelioma Survival
Chemotherapy | New Studies | Research | Treatments

Paclitaxel May Prevent Metastatic Peritoneal Mesothelioma in High Risk People
ByAlex Strauss May 14, 2021

Administering the chemotherapy drug paclitaxel directly into the abdomen of people with mesothelioma might offer a way to prevent metastatic…

Read More Paclitaxel May Prevent Metastatic Peritoneal Mesothelioma in High Risk People
Biopsy | Diagnosis | New Studies | Research

Immunohistochemical Staining and Sarcomatoid Mesothelioma: Beyond the Lab
ByAlex Strauss May 5, 2021

When it comes to understanding individual cases of sarcomatoid mesothelioma, doctors should not rely too heavily on immunohistochemical staining. That…

Read More Immunohistochemical Staining and Sarcomatoid Mesothelioma: Beyond the Lab
Europe | Immune Systems | Immunotherapy | International | Research | Treatments

Different Mesothelioma Subtypes: Gene Study Could Lead to Targeted Treatments
ByAlex Strauss April 30, 2021

A group of European pathologists say the different mesothelioma subtypes have significant differences in their pattern of gene expression. Exploiting…

Read More Different Mesothelioma Subtypes: Gene Study Could Lead to Targeted Treatments
Europe | Genetics | Immunotherapy | International | Research | Treatments

Long-Term Mesothelioma Survival With Immunotherapy Combination
ByAlex Strauss April 13, 2021

An immunotherapy combination of tremelimumab and durvalumab has resulted in long-term survival for some mesothelioma patients in a new follow-up…

Read More Long-Term Mesothelioma Survival With Immunotherapy Combination
Genetics | Immune Systems | Research

Genetic Links to Mesothelioma Illustrated in New Interactive Model
ByAlex Strauss April 8, 2021

An interactive model of protein interactions could reveal new genetic links to mesothelioma and even lead to new treatments. The…

Read More Genetic Links to Mesothelioma Illustrated in New Interactive Model
Europe | International | New Studies | Research | Surgery | Treatments

CRS/HIPEC Procedure Has Improved Over Time, Study Finds
ByAlex Strauss April 4, 2021

A new French study contains some good news for people considering the CRS/HIPEC procedure for peritoneal mesothelioma. The CRS/HIPEC procedure…

Read More CRS/HIPEC Procedure Has Improved Over Time, Study Finds
Chemotherapy | New Studies | Research | Treatments

Real-World Mesothelioma Patients Need New Systemic Treatments
ByAlex Strauss March 28, 2021

The newest study on real-world mesothelioma patients illustrates the need for more ways to treat this devastating cancer. Many studies…

Read More Real-World Mesothelioma Patients Need New Systemic Treatments
Asia | Biopsy | Diagnosis | International | New Studies | Research | Symptoms | Treatments | Updates

Irradiating Procedure Tracts Reduces Metastatic Mesothelioma in New Study
ByAlex Strauss March 8, 2021

Irradiating the tracts through which certain interventions are performed can reduce the risk of metastatic pleural mesothelioma. That word comes…

Read More Irradiating Procedure Tracts Reduces Metastatic Mesothelioma in New Study

1 (888) 378-1331

Research

Risk of Mesothelioma in Women May be Underestimated

Higher PD-L1 Protein May Predict Shorter Mesothelioma Survival

Paclitaxel May Prevent Metastatic Peritoneal Mesothelioma in High Risk People

Immunohistochemical Staining and Sarcomatoid Mesothelioma: Beyond the Lab

Different Mesothelioma Subtypes: Gene Study Could Lead to Targeted Treatments

Long-Term Mesothelioma Survival With Immunotherapy Combination

Genetic Links to Mesothelioma Illustrated in New Interactive Model

CRS/HIPEC Procedure Has Improved Over Time, Study Finds

Real-World Mesothelioma Patients Need New Systemic Treatments

Irradiating Procedure Tracts Reduces Metastatic Mesothelioma in New Study

United States Sources

Centers for Disease Control and Prevention (CDC), UNITED STATES

Creighton University School of Medicine, UNITED STATES

David Geffen School of Medicine, UCLA, UNITED STATES

Icahn School of Medicine at Mount Sinai, New York, UNITED STATES

Mayo Clinic, UNITED STATES

Moffitt Cancer Center, Tampa, FL, UNITED STATES

National Institute for Occupational Safety & Health, UNITED STATES

University of Chicago, Medical Center, UNITED STATES

University of Maryland School of Medicine, UNITED STATES

University of Hawaii Cancer Center, UNITED STATES

Wake Forest University School of Medicine, UNITED STATES